Cardiotrophin-1 Is a Key Regulator of Glucose and Lipid Metabolism
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Cardiotrophin-1 (CT-1) is a member of the gp130 family of cytokines. We observed that ct-1(-/-) mice develop mature-onset obesity, insulin resistance, and hypercholesterolemia despite reduced calorie intake. Decreased energy expenditure preceded and accompanied the development of obesity. Acute treatment with rCT-1 decreased blood glucose in an insulin-independent manner and increased insulin-stimulated AKT phosphorylation in muscle. These changes were associated with stimulation of fatty acid oxidation, an effect that was absent in AMPKα2(-/-) mice. Chronic rCT-1 treatment reduced food intake, enhanced energy expenditure, and induced white adipose tissue remodeling characterized by upregulation of genes implicated in the control of lipolysis, fatty acid oxidation, and mitochondrial biogenesis and genes typifying brown fat phenotype. Moreover, rCT-1 reduced body weight and corrected insulin resistance in ob/ob and in high-fat-fed obese mice. We conclude that CT-1 is a master regulator of fat and glucose metabolism with potential applications for treatment of obesity and insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 1×
“Our data demonstrate that rCT-1 activates AMPK in muscle and that AMPKa2 mediates the stimulatory effect of CT-1 on fatty acid oxidation, as has also been reported for leptin and CNTF (Minokoshi et al., 2002; Watt et al., 2006).”
BackgroundHypothalamic mTOR Signaling Regulates Food Intake
Cota, D., Proulx, K., Smith, K. A. B., Kozma, S. C., Thomas, G., Woods, S. C., & Seeley, R. J. (2006) · Science · doi:10.1126/science.1124147 · Cited by 1,278
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 3×
“While some reports showed that il-6 null mice were hyperphagic and developed mature-onset obesity (Wallenius et al., 2002), other investigators did not observe obesity or abnormal lipid metabolism in those animals (Di Gregorio et al., 2004).”
ResultTranscriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174 · cited 4×
“This was reflected by (1) upregulation of genes implicated in the control of mitochondrial function and regulation of BAT (PGC-1a, transcription factor A mitochondrial [TFAM], NRF1, eNOS, uncoupling protein [UCP] 2, UCP1, PRDM16, and deiodinase iodothyronine type II [Dio2]) (Figure 2E), (2) increased content of the mt…”
BackgroundInfluentialSteensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095 · cited 2×
“, 2004) and released (Steensberg et al., 2000) from skeletal muscle during exercise led many to challenge this concept, as insulin action is enhanced immediately after exercise (Wojtaszewski and Richter, 2006).”
BackgroundBonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819 · cited 1×
“Total DNA was extracted from epididymal fat using QIAamp DNA kit (QIAGEN), and mtDNA was calculated using real-time quantitative PCR as previously described (Bonnard et al., 2008).”
MethodMitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., & Corvera, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21752 · Cited by 616 · cited 1×
“Adipocyte Oxygen Consumption, Mitochondrial Content, and Mitochondrial DNA Adipocytes were isolated from epididymal fat, and oxygen consumption was measured in a BD Oxygen Biosensor System plate (BD Biosciences) as previously described (Wilson-Fritch et al., 2004).”
MethodHigh-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538 · cited 1×
“It has been reported that increased lipid availability observed in obesity enhances the capacity of muscle for fat oxidation (Hancock et al., 2008; Turner et al., 2007).”
BackgroundExcess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J. (2007) · Diabetes · doi:10.2337/db07-0093 · Cited by 520 · cited 1×
“It has been reported that increased lipid availability observed in obesity enhances the capacity of muscle for fat oxidation (Hancock et al., 2008; Turner et al., 2007).”
BackgroundThe AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16567 · Cited by 499 · cited 2×
“AMPKa2 / were generated as described (Viollet et al., 2003) and used at 8 weeks of age.”
BackgroundMethodSelf-citation
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Pleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533
Leptin resistance and diet-induced obesity: central and peripheral actions of leptin
Sáinz, N., Barrenetxe, J., Moreno-Aliaga, M. J., & Martínez, J. A. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.015 · Cited by 423
Self-citationPeirce, V., Carobbio, S., & Vidal-Puig, A. (2014) · Nature · doi:10.1038/nature13477 · Cited by 415
Beyond the Sympathetic Tone: The New Brown Fat Activators
Villarroya, F., & Vidal-Puig, A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.020 · Cited by 209
Laiglesia, L. M., Lorente-Cebrián, S., Prieto-Hontoria, P. L., Fernández-Galilea, M., Ribeiro, S. M. R., Sáinz, N., Martínez, J. A., & Moreno-Aliaga, M. J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.07.019 · Cited by 85
Self-citation
Metadata
- Authors
- Moreno-Aliaga, M. J., Pérez-Echarri, N., Marcos-Gómez, B., Larequi, E., Gil-Bea, F. J., Viollet, B., Gimenez, I., Martínez, J. A., Prieto, J., & Bustos, M.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 14
- Issue
- 2
- Pages
- 242-253
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2069270713
- Cited by
- 114
- References
- 17
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.